Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amirhossein Sakhteman

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Molecular Systems Biology|January 21, 2025
Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage responseStefanie Höfer, Larissa Frasch, Sarah Brajkovic, et al.
Nucleic Acids Research|November 17, 2025
Mapping drug mechanisms with ProteomicsDB: unified omics and cell sensitivity data at scaleMario Picciani, Armin Soleymaniniya, Julian Müller, et al.
Science Signaling|July 29, 2025
Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signalingNicole Kabella, Florian P Bayer, Konstantinos Stamatiou, et al.
ACS Chemical Biology|May 9, 2025
Serendipitous and Systematic Chemoproteomic Discovery of MBLAC2, HINT1, and NME1-4 Inhibitors from Histone Deacetylase-Targeting PharmacophoresSeverin Lechner, Shuyao Sha, Jigar Paras Sethiya, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Molecular Systems Biology|January 21, 2025
Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage responseStefanie Höfer, Larissa Frasch, Sarah Brajkovic, et al.
Nucleic Acids Research|November 17, 2025
Mapping drug mechanisms with ProteomicsDB: unified omics and cell sensitivity data at scaleMario Picciani, Armin Soleymaniniya, Julian Müller, et al.
Science Signaling|July 29, 2025
Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signalingNicole Kabella, Florian P Bayer, Konstantinos Stamatiou, et al.
ACS Chemical Biology|May 9, 2025
Serendipitous and Systematic Chemoproteomic Discovery of MBLAC2, HINT1, and NME1-4 Inhibitors from Histone Deacetylase-Targeting PharmacophoresSeverin Lechner, Shuyao Sha, Jigar Paras Sethiya, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Pageof 8